HEALTH

The First Gene Therapy for Genetic Hearing Loss Is Here

From Advancing Tomorrow · August 22, 2026 · Curated by DeafMonitor

Otarmeni is the first FDA-approved gene therapy for genetic hearing loss in the United States—and it is allowing some people ...

DeafMonitor aggregates Deaf-community news and credits every story to its original publisher. This story was reported by Advancing Tomorrow.
Read the full story at Advancing Tomorrow

Open in the live feed Browse all stories

More Health stories

TNMSC to procure assistive devices, retrofitted scooters for Differently Abled Welfare Department August 23, 2026
TNMSC to procure assistive devices, retrofitted scooters for Welfare of the Differently Abled Persons Department August 22, 2026
How hearing loss can affect learning - FOX 9 Minneapolis-St. Paul August 21, 2026
Children’s Wisconsin first in nation to offer gene therapy for hearing loss outside trial August 20, 2026
Children's Wisconsin first to provide FDA-approved gene therapy for hearing loss August 20, 2026
Children’s Wisconsin delivers first FDA-approved gene therapy for genetic hearing loss outside clinical trial August 19, 2026